An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

NCT00403481 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: olmesartan medoxomil
DRUG: Olmesartan medoxomil plus Hydrochlorothiazide

Sponsor

Daiichi Sankyo